SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
Silexion Therapeutics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.15+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $105.17K
- P/E (TTM)
- 0.0
- Dividend yield
- –
SEC filings
40 of Silexion Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Oct 5, 2026 | Oct 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2026 | Sep 30, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 24, 2026 | Aug 24, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2026 | Jul 21, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 16, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | May 19, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2026 | Apr 28, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 9, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2026 | Mar 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 17, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 6, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 16, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 2, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 25, 2025 | Nov 25, 2025 | SEC EDGAR |